InnoCare Pharma Limited
INCPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $5,747 | $28,311 | $42,503 | $38,428 |
| - Cash | $958 | $7,056 | $7,008 | $6,223 |
| + Debt | $234 | $1,538 | $1,545 | $1,272 |
| Enterprise Value | $5,024 | $22,793 | $37,040 | $33,477 |
| Revenue | $54 | $350 | $381 | $312 |
| % Growth | -84.6% | -8.2% | 22.3% | – |
| Gross Profit | $47 | $310 | $345 | $271 |
| % Margin | 87.4% | 88.4% | 90.5% | 87% |
| EBITDA | -$3 | -$89 | -$3 | -$121 |
| % Margin | -4.9% | -25.3% | -0.9% | -39% |
| Net Income | -$5 | -$48 | $18 | -$165 |
| % Margin | -8.9% | -13.7% | 4.7% | -53% |
| EPS Diluted | -0.003 | -0.04 | 0.01 | -0.1 |
| % Growth | 93.2% | -496% | 110% | – |
| Operating Cash Flow | -$0 | -$118 | $57 | -$32 |
| Capital Expenditures | -$2 | -$10 | -$15 | -$7 |
| Free Cash Flow | -$2 | -$128 | $41 | -$39 |